Ingredient Guide
Ceylon Cinnamon: Benefits, Dosage, and What the Research Says
True cinnamon explained - what clinical research shows about blood sugar, lipids, and safety.
Written by Jessica Medson
Ceylon cinnamon (Cinnamomum verum) is the botanical species historically regarded as true cinnamon, distinguished from common cassia varieties by its trace coumarin content (about 0.004% dry weight) and a richer polyphenol profile. An umbrella meta-analysis synthesizing 11 meta-analyses of randomized controlled trials found that cinnamon supplementation reduced fasting plasma glucose by nearly 11 mg/dL and improved insulin resistance markers in people with type 2 diabetes or PCOS.<sup><a href="#ref-1">1</a></sup> Evidence on lipid support and postprandial glucose response is also emerging from human trials, though effect sizes are modest and most research has been conducted in populations with existing metabolic conditions.
What Is Ceylon Cinnamon?
Ceylon cinnamon (Cinnamomum verum, also listed as C. zeylanicum) is the botanical species historically regarded as true cinnamon. Native to Sri Lanka and southern India, it is distinct from the cassia varieties - including C. cassia, C. aromaticum, and C. burmannii - that make up the vast majority of cinnamon sold in North American supermarkets. Both types come from the inner bark of cinnamon trees, but they differ substantially in chemical composition, flavor, and safety profile.
How to identify Ceylon cinnamon
Ceylon quills are soft, thin-layered, and easily crumbled, with a cross-section showing multiple tight layers of bark folded inward from both sides. Cassia sticks are harder, hollow, and thicker-walled. The flavor of Ceylon is milder, more delicate, and slightly sweet, while cassia tastes sharper and more pungent. On supplement labels, look for Cinnamomum verum, C. zeylanicum, or the explicit designation "Ceylon cinnamon" to confirm species identity.
The chemical difference that matters most for supplementation is coumarin content. Chemical profiling across Cinnamomum species shows Ceylon cinnamon contains only about 0.004% coumarin by dry weight, while cassia specimens can reach up to 5.64%.8 Coumarin at high doses is associated with hepatotoxicity, and European regulators have established a tolerable daily intake of 0.1 mg per kilogram of body weight per day - an amount easily exceeded with regular cassia supplement use but not with certified Ceylon cinnamon.6
Ceylon cinnamon also has a distinct bioactive profile: cinnamaldehyde makes up roughly 70-90% of the essential oil, accompanied by trans-cinnamic acid, eugenol, and a family of type-A polymeric procyanidins. These are the compounds that drive the metabolic effects studied in clinical research. Today, Cinnamomum verum is the species of choice for supplement formulations targeting blood sugar and metabolic health support.
How Does It Work?
Ceylon cinnamon's metabolic effects arise from several bioactive compounds acting through complementary pathways. While much of the mechanistic detail is preclinical, these pathways are consistent with the clinical outcomes measured in human trials.
Cinnamaldehyde and AMPK activation
Cinnamaldehyde - the aldehyde responsible for cinnamon's characteristic aroma - is the primary active compound. Pharmacological reviews show it activates AMP-activated protein kinase (AMPK), a cellular energy sensor that promotes glucose uptake into muscle cells, enhances fat oxidation, and reduces hepatic glucose production. Cinnamaldehyde also upregulates GLUT4 gene expression in skeletal muscle, increasing the number of insulin-sensitive glucose transporters available to shuttle sugar from the bloodstream into cells.9 Separately, it has been shown to enhance Akt2 phosphorylation, amplifying downstream insulin receptor signaling.
Polymeric procyanidins as insulin mimetics
Type-A polymeric procyanidins in cinnamon bark have been shown in cell-based studies to act as insulin mimetics - binding to insulin receptor kinase and stimulating GLUT4 translocation without requiring insulin itself. This preclinical mechanism may help explain why glucose-lowering effects appear in both fasting and postprandial contexts in human trials. Direct evidence of this pathway in humans has not yet been established; this should be considered Tier C (preclinical) evidence only.
Alpha-amylase inhibition
A third documented mechanism involves inhibition of pancreatic alpha-amylase, the enzyme that breaks down dietary starch into absorbable glucose. A randomized, double-blind, placebo-controlled crossover trial in 18 healthy volunteers found that 1 g of hydro-alcoholic Ceylon cinnamon extract reduced blood glucose by 21.2% during the first 60 minutes after a standardized starchy meal (P < 0.05), without stimulating insulin secretion.2 The extract exhibited an IC50 of 25 µg/mL for pancreatic alpha-amylase inhibition in that study, comparable to the drug acarbose in the same assay. These three mechanisms converge on the insulin-signaling and glucose-absorption pathways - which is consistent with the clinical endpoints measured in human trials.
Blood Sugar Support and Insulin Sensitivity
Blood glucose regulation is the most-studied application of cinnamon supplementation, with a substantial body of clinical literature - including multiple meta-analyses of randomized controlled trials - examining its effects in people with type 2 diabetes and insulin resistance.
What the research shows
An umbrella meta-analysis synthesizing 11 separate meta-analyses of RCTs found that cinnamon supplementation produced statistically significant reductions across all major glycemic markers in people with type 2 diabetes or PCOS:1
- Fasting plasma glucose (FPG): weighted mean difference (WMD) -10.93 mg/dL (95% CI: -16.22 to -5.65)
- Fasting insulin: WMD -2.01 IU/mL (95% CI: -3.96 to -0.07)
- HOMA-IR (insulin resistance index): WMD -0.61 (95% CI: -0.91 to -0.31)
- HbA1c: WMD -0.10% (95% CI: -0.17 to -0.03)
A 2023 dose-response meta-analysis of RCTs found that at doses at or below 1,200 mg per day, fasting blood glucose decreased by 11.1 mg/dL (95% CI: -14.64 to -7.58; P < 0.001). Above that dose threshold, the benefit attenuated - suggesting that more is not necessarily better.10
A 2025 double-blind, placebo-controlled RCT specifically using Cinnamomum zeylanicum (Ceylon) extract enrolled 150 adults and found that those receiving cinnamon showed a significantly greater reduction in fasting blood sugar over 12 weeks (baseline-adjusted mean difference: -8.59 mg/dL; 95% CI: -0.59 to -16.59; P = 0.036) versus placebo.5 In the diabetic subgroup specifically, the reduction was larger: -63 mg/dL (95% CI: -102 to -25; P = 0.002).
Postprandial glucose response
Beyond fasting glucose, Ceylon cinnamon has been studied for its acute effect on blood sugar after meals. In the crossover trial cited above, a single 1 g dose of Ceylon cinnamon extract reduced blood glucose by 21.2% in the first hour following a starchy meal (P < 0.05), without triggering additional insulin release - an effect attributed to alpha-amylase inhibition in the gut.2
Putting the evidence in perspective
The magnitude of fasting glucose reduction in these trials (-9 to -11 mg/dL) is clinically modest. For context, metformin typically reduces FPG by 25-60 mg/dL at therapeutic doses. Cinnamon may be best understood as a complementary dietary support measure rather than a replacement for prescribed medication. The research also comes predominantly from people already living with type 2 diabetes or significant insulin resistance; effects in healthy individuals with normal glucose metabolism may differ. Most study durations do not exceed 16 weeks, so long-term effects have not yet been established.
Lipid Profile and Cardiovascular Markers
A secondary area of clinical research concerns cinnamon's effect on blood lipids - including triglycerides, LDL cholesterol, and HDL cholesterol - in people with metabolic conditions.
What the research shows
A 2023 dose-response meta-analysis of RCTs in people with type 2 diabetes found that cinnamon supplementation produced significant improvements across key lipid markers:10
- Triglycerides: -7.31 mg/dL (95% CI: -12.37 to -2.25; P = 0.005)
- LDL cholesterol: -6.78 mg/dL (95% CI: -11.35 to -2.22; P = 0.004)
- HDL cholesterol: +1.53 mg/dL (95% CI: +1.01 to +2.05; P < 0.001)
A separate 2024 meta-analysis of 10 RCTs found a statistically significant overall reduction in triglycerides (-6.88 mg/dL; 95% CI: -12.62 to -1.15), with more pronounced effects at doses below 500 mg per day. Effects on total cholesterol and LDL did not reach overall significance in that analysis, though the lower-dose subgroup showed a meaningful LDL reduction of -10.26 mg/dL.4 The researchers noted high heterogeneity across studies, which limits definitive conclusions.
In the 3-month Phase I clinical trial using Ceylon cinnamon extract in 30 healthy adults, participants showed significant reductions in total cholesterol (P < 0.05) and LDL cholesterol (P < 0.001) by study completion, while HDL, VLDL, and triglycerides remained within the normal range throughout.3
What this means in practice
The lipid-modifying effects of cinnamon appear real but modest, and evidence is somewhat stronger for triglycerides than for LDL. High heterogeneity across studies - driven by differences in cinnamon species and form, dose, duration, and participants' baseline health - means individual responses may vary. These findings support cinnamon's role in broader metabolic health, but should not be interpreted as evidence that it replaces lipid-lowering therapy in people with cardiovascular disease risk.
Emerging Research: Women with PCOS
An emerging body of clinical research has examined cinnamon supplementation in women with polycystic ovary syndrome (PCOS), a condition characterized by insulin resistance, hyperandrogenism, and irregular ovulation. Because insulin resistance is central to PCOS pathophysiology, cinnamon's insulin-sensitizing properties have attracted specific research interest in this population.
What the research shows
A randomized, double-blind, placebo-controlled trial enrolled women with PCOS and assigned them to cinnamon (1,500 mg/day in divided doses), ginger, metformin, or placebo for 8 weeks. Cinnamon supplementation significantly reduced insulin resistance, measured by HOMA-IR, from 2.15 ± 1.91 to 1.53 ± 0.92 (P = 0.01) - a reduction comparable in magnitude to metformin, which reduced HOMA-IR from 1.98 ± 0.92 to 1.58 ± 0.51 in the same trial (P = 0.01). Cinnamon also significantly reduced testosterone levels (from 61.05 to 50.05 ng/dL), a marker of hyperandrogenism in PCOS. Neither ginger nor placebo produced significant changes in HOMA-IR.7
The umbrella meta-analysis of glycemic RCTs also included PCOS trials alongside T2DM trials and similarly reported significant pooled reductions in insulin, fasting plasma glucose, and HOMA-IR across both populations.1
What this means in practice
The PCOS-specific evidence is promising but currently limited to a small number of short-duration trials with relatively modest sample sizes. This should be considered preliminary human evidence. Women with PCOS who are interested in cinnamon supplementation should discuss it with their healthcare provider, particularly given potential additive effects with insulin-sensitizing medications such as metformin.
Safety, Side Effects, and Interactions
Ceylon cinnamon has a well-documented safety profile at typical supplemental doses, but several important considerations apply for specific populations and medication users.
General safety at supplemental doses
A 3-month Phase I clinical trial dose-escalated Ceylon cinnamon extract from 85 mg to 250 mg to 500 mg per day across monthly intervals in 30 healthy adults. No serious adverse events were observed. Full blood count, liver function tests, renal function tests, and fasting blood glucose all remained within normal range throughout the three months. Only two participants discontinued due to mild dyspepsia.3
An umbrella review of meta-analyses and systematic reviews of RCTs specifically evaluating cinnamon safety concluded that available evidence supports no significant toxic or side effects between cinnamon and placebo groups, regardless of dose or duration studied.6
Coumarin - why Ceylon cinnamon matters
While Ceylon cinnamon contains only about 0.004% coumarin by dry weight, cassia varieties can contain up to 5.64%.8 Coumarin at high doses has been associated with hepatotoxic effects, and the European Food Safety Authority has set a tolerable daily intake (TDI) of 0.1 mg per kilogram of body weight per day. At supplemental doses using certified Ceylon cinnamon, coumarin exposure is negligible. Consumers should verify that products specify Cinnamomum verum or "Ceylon cinnamon" on the label, as mislabeling of cassia as Ceylon has been documented in some markets.
Potential drug interactions
Ceylon cinnamon has documented glucose-lowering activity in clinical trials. People taking the following medications should consult their healthcare provider before use:
- Blood-sugar-lowering medications (insulin, metformin, sulfonylureas, GLP-1 receptor agonists): cinnamon may have additive glucose-lowering effects, potentially increasing hypoglycemia risk.
- Anticoagulants and blood thinners (warfarin, clopidogrel): cinnamon contains compounds with mild antiplatelet activity; monitor closely if combining.
- Antihypertensive medications: an umbrella review of metabolic disease RCTs reported modest blood-pressure-lowering effects (SMD -0.79 for systolic, -0.52 for diastolic), rated as weak evidence; those on antihypertensives should be aware.11
Special populations
- Pregnancy and breastfeeding: There is insufficient clinical evidence to establish safety at supplemental doses during pregnancy or lactation. Culinary amounts of cinnamon in food are generally considered safe, but supplement-level doses have not been systematically studied in pregnant women. Avoid supplement use during pregnancy unless directed by a healthcare provider.
- Liver disease: Although Ceylon cinnamon's coumarin content is minimal, individuals with pre-existing hepatic conditions should consult a physician before use.
- Children: Supplemental doses of Ceylon cinnamon have not been systematically evaluated in pediatric populations.
Ceylon Cinnamon Dosage Guide
Doses below are drawn from the clinical trials reviewed above. Individual responses vary; start at a lower dose and work up. These are not medical instructions - consult your healthcare provider, especially if you take medications.
| Goal | Typical Dose | Timing | Notes |
|---|---|---|---|
| Metabolic health support (general wellness) | 500-1,000 mg/day | With meals | Range used in Phase I safety trial; escalated from 85 mg to 500 mg over 3 months with no serious adverse events |
| Blood glucose support (populations studied: T2DM, PCOS) | 1,000-2,000 mg/day | Divided doses with meals | Dose-response data suggest FBG benefit peaks around 1,200 mg/day; most RCTs run 8-16 weeks; not a substitute for diabetes medication |
| Postprandial glucose response (after starchy meals) | 1 g standardized extract | Before or with a starchy meal | Based on one n=18 crossover RCT; 21.2% reduction in first-hour postprandial glucose versus placebo |
All studies used ground bark powder or water/hydro-alcoholic extract of Cinnamomum verum. Ensure the product specifies Ceylon cinnamon (C. verum) on the label, not cassia.
Ceylon vs. Cassia Cinnamon - Key Differences
Not all cinnamon supplements are equal. The species on the label determines your coumarin exposure and safety profile at regular supplemental doses.
| Feature | Ceylon Cinnamon (C. verum) | Cassia Cinnamon (C. cassia / C. burmannii) |
|---|---|---|
| Coumarin content | ~0.004% dry weight | Up to 5.64% dry weight |
| Hepatotoxicity risk at typical supplement doses | Minimal | Possible with high or long-term intake |
| EU tolerable daily intake exceeded at supplement doses? | No | Potentially yes |
| Flavor profile | Mild, delicate, slightly sweet | Sharp, pungent, more intense |
| Quill appearance | Soft, multi-layered, easily crumbled | Hard, hollow, single thick layer |
| Primary growing region | Sri Lanka, southern India | Vietnam, China, Indonesia |
| Preferred species for clinical supplementation | Yes - confirmed in most modern RCTs | Caution advised; not specified in many safety reviews |
Sources: Rana & Sheu 2023 (PMID 37599847); Gu et al. 2022 (PMID 35115937). Mislabeling of cassia as Ceylon has been documented in commercial markets.
Frequently Asked Questions
What is Ceylon cinnamon good for?
Clinical research suggests Ceylon cinnamon may help support healthy blood sugar levels within the normal range, improve insulin sensitivity, and modestly lower triglycerides. An umbrella meta-analysis of 11 RCT meta-analyses found reductions of nearly 11 mg/dL in fasting plasma glucose and meaningful improvements in HOMA-IR in people with type 2 diabetes or PCOS.
How much Ceylon cinnamon should I take per day?
Most clinical trials used 500 mg to 2,000 mg per day of ground bark or standardized extract with meals. Dose-response data suggest blood glucose benefits peak around 1,200 mg/day. A Phase I safety trial found no serious adverse events escalating from 85 mg to 500 mg over three months. Start low and consult your provider.
What is the difference between Ceylon cinnamon and regular cinnamon?
"Regular" grocery-store cinnamon is almost always cassia (C. cassia or C. burmannii), which can contain coumarin levels up to 5.64% dry weight. Ceylon cinnamon (C. verum) contains only about 0.004% coumarin, making it substantially safer for long-term supplementation. Physically, Ceylon quills are soft and multi-layered; cassia sticks are hard and hollow.
Does Ceylon cinnamon lower blood sugar?
Research in people with type 2 diabetes suggests it may help maintain blood sugar within the normal range. A 2025 RCT using Ceylon cinnamon extract found an 8.59 mg/dL reduction in fasting blood sugar versus placebo over 12 weeks (P = 0.036), with a larger effect in the diabetic subgroup. It is not a substitute for diabetes medication.
Is Ceylon cinnamon safe to take every day?
At typical supplemental doses, the available evidence is reassuring. A 3-month Phase I trial found no serious adverse events and normal liver and kidney parameters throughout. An umbrella safety review found no significant toxic or side effects versus placebo across RCTs studied. People taking glucose-lowering or anticoagulant medications should consult a physician first.
Does Ceylon cinnamon help with weight loss?
Direct evidence for weight loss from Ceylon cinnamon supplementation is limited. Some RCTs in people with PCOS and metabolic syndrome report modest reductions in BMI alongside other metabolic improvements, but these trials typically combine supplementation with dietary changes. Ceylon cinnamon cannot currently be recommended as a primary weight-management strategy.
Can Ceylon cinnamon interact with medications?
Yes. Because it has documented blood-sugar-lowering activity, it may amplify the effect of insulin, metformin, sulfonylureas, and GLP-1 agonists - raising hypoglycemia risk. It also contains mild antiplatelet compounds, so people on anticoagulants like warfarin should use caution. A modest blood-pressure-lowering effect has been reported; discuss with your provider if you take antihypertensives.
Can I take Ceylon cinnamon if I already take diabetes medication?
Discuss it with your doctor before adding it to an existing diabetes regimen. Because cinnamon has its own glucose-lowering activity, combining it with insulin or oral hypoglycemics without monitoring could increase hypoglycemia risk. Your provider may want to track blood glucose more closely if you choose to supplement alongside prescription medications.
Is Ceylon cinnamon safe during pregnancy?
There is insufficient clinical evidence to confirm safety at supplemental doses during pregnancy or breastfeeding. Culinary amounts of cinnamon in food are generally considered safe, but supplement-level doses have not been systematically studied in pregnant women. Consult your OB-GYN or midwife before using any cinnamon supplement while pregnant or nursing.
How long does it take for Ceylon cinnamon to work?
Most RCTs measuring metabolic effects run 8 to 16 weeks, and measurable changes in fasting glucose and lipids emerge within that window. One crossover trial showed an acute postprandial effect within 60 minutes of a single dose. For chronic benefits such as HbA1c reduction, consistent daily supplementation over at least 8-12 weeks appears necessary based on published trial timelines.
Shop Ceylon Cinnamon
HealthFare Ceylon Cinnamon supplements
Scientific References
- 1.Zarezadeh M, Musazadeh V, Foroumandi E, Keramati M, Ostadrahimi A, Mekary RA The effect of cinnamon supplementation on glycemic control in patients with type 2 diabetes or with polycystic ovary syndrome: an umbrella meta-analysis on interventional meta-analyses. Diabetology and Metabolic Syndrome. 2023. PubMed: 37316893Clinical (RCT / meta-analysis)
- 2.Beejmohun V, Peytavy-Izard M, Mignon C, Muscente-Paque D, Deplanque X, Ripoll C, Chapal N Acute effect of Ceylon cinnamon extract on postprandial glycemia: alpha-amylase inhibition, starch tolerance test in rats, and randomized crossover clinical trial in healthy volunteers. BMC Complementary and Alternative Medicine. 2014. PubMed: 25249234Clinical (RCT / meta-analysis)
- 3.Ranasinghe P, Jayawardena R, Pigera S, Wathurapatha WS, Weeratunga HD, Premakumara GAS, Katulanda P, Constantine GR, Galappaththy P Evaluation of pharmacodynamic properties and safety of Cinnamomum zeylanicum (Ceylon cinnamon) in healthy adults: a phase I clinical trial. BMC Complementary and Alternative Medicine. 2017. PubMed: 29282046Clinical (RCT / meta-analysis)
- 4.Fateh HL, Amin SM Effects of Cinnamon Supplementation on Lipid Profile: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. Clinical Nutrition Research. 2024. PubMed: 38362130Clinical (RCT / meta-analysis)
- 5.Muthukuda D, de Silva CK, Ajanthan S, Wijesinghe N, Dahanayaka A, Pathmeswaran A Effects of Cinnamomum zeylanicum (Ceylon cinnamon) extract on lipid profile, glucose levels and its safety in adults: A randomized, double-blind, controlled trial. PLoS One. 2025. PubMed: 39854533Clinical (RCT / meta-analysis)
- 6.Gu DT, Tung TH, Jiesisibieke ZL, Chien CW, Liu WY Safety of Cinnamon: An Umbrella Review of Meta-Analyses and Systematic Reviews of Randomized Clinical Trials. Frontiers in Pharmacology. 2022. PubMed: 35115937Clinical (RCT / meta-analysis)
- 7.Dastgheib M, Barati-Boldaji R, Bahrampour N, Taheri R, Borghei M, Amooee S, Mohammadi-Sartang M, Wong A, Babajafari S, Mazloomi SM A comparison of the effects of cinnamon, ginger, and metformin consumption on metabolic health, anthropometric indices, and sexual hormone levels in women with polycystic ovary syndrome: A randomized double-blinded placebo-controlled clinical trial. Frontiers in Nutrition. 2022. PubMed: 36523331Clinical (RCT / meta-analysis)
- 8.Rana P, Sheu SC Discrimination of four Cinnamomum species by proximate, antioxidant, and chemical profiling: towards quality assessment and authenticity. Journal of Food Science and Technology. 2023. PubMed: 37599847Preclinical (animal / cell)
- 9.Guo J, Yan S, Jiang X, Su Z, Zhang F, Xie J, Hao E, Yao C Advances in pharmacological effects and mechanism of action of cinnamaldehyde. Frontiers in Pharmacology. 2024. PubMed: 38903995Preclinical (animal / cell)
- 10.Yu T, Lu K, Cao X, Xia H, Wang S, Sun G, Chen L, Liao W The Effect of Cinnamon on Glycolipid Metabolism: A Dose-Response Meta-Analysis of Randomized Controlled Trials. Nutrients. 2023. PubMed: 37447309Clinical (RCT / meta-analysis)
- 11.Gou H, Zhong L, Wei Q, Fan Y The effects of cinnamon on patients with metabolic diseases: an umbrella review of meta-analyses of randomized controlled trials. Frontiers in Nutrition. 2025. PubMed: 41256917Clinical (RCT / meta-analysis)